Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome

Neurology

Volumn 50, Issue 2, 1998, Pages 470-475

  Katz, J S ^a,b   Wolfe, G I ^a   Bryan, W W ^a   Tintner, R ^a   Barohn, Richard J ^a,c  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CHOLINERGIC RECEPTOR ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; AREFLEXIA; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; EATON LAMBERT SYNDROME; ELECTRODIAGNOSIS; FEMALE; HUMAN; MALE; MUSCLE ACTION POTENTIAL; PRIORITY JOURNAL;

EID: 0031934647     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.2.470     Document Type: Article

References (35)

1. Takamori M, Gutmann L. Intermittent defect of acetylcholine release in myasthenia gravis. Neurology 1971;21:47-54.
2. Dahl DS, Sato S. Unusual myasthenic state in a teen-age boy. Neurology 1974;24:897-901.
3. Oh SJ. The Eaton-Lambert syndrome in ocular myasthenia gravis. Arch Neurol 1974;31:183-186.
4. Schwartz M, Stalberg E. Myasthenia gravis with features of the myasthenic syndrome. Neurology 1975;25:80-84.
5. Mori M, Takamori M. Hyperthyroidism and myasthenia gravis with features of Lambert-Eaton syndrome. Neurology 1976;26:882-887.
6. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptors in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 1976;26:1054-1059.
7. Fettell MR, Shin HS, Penn AS, Lovelace RE, Rowland LP. Combined Eaton-Lambert syndrome and myasthenia gravis. Neurology 1978;28:398. Abstract.
8. Tabbaa MA, Leschner RT, Campbell WW. Malignant thymoma with dysautonomia and disordered neuromuscular transmission. Arch Neurol 1986;43:955-957.
9. Oh SJ, Dwyer DS, Bradley RJ. Overlap myasthenic syndrome: combined myasthenia gravis and Eaton-Lambert syndrome. Neurology 1987;37:1411-1414.
10. Taphoorn MJB, Van Duijn H, Wolters ECH. A neuromuscular transmission disorder: combined myasthenia gravis and Lambert-Eaton syndrome in one patient. J Neurol Neurosurg Psychiatry 1988;51:880-882.
11. Newsom-Davis J, Leys K, Ferguson I, Modi G, Mills K. Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients. J Neurol Neurosurg Psychiatry 1991;54:452-453.
12. Lennon VA, Kryzer TJ, Greismann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
13. Lennon, VA, Lambert EH, Whittingham S, Fairbanks V. Autoimmunity in the Lambert-Eaton Syndrome. Muscle Nerve 1982;5:S21-S25.
14. Lennon VA. Serological diagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. In: Liak R, ed. Handbook of myasthenia gravis and myasthenic syndromes. New York: Marcel Dekker, 1994:149-164.
15. Sanders DB. Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update on therapies. Ann Neurol 1995;37(S1):S63-S73.
16. O'Neill, Murray NMF, Newsom-Davis J. The Lambert Eaton myasthenic syndrome. Brain 1988;111:577-596.
17. Nilson O, Rosen I. The stretch reflex in the Lambert-Eaton syndrome, myasthenia gravis, myotonic dystrophy. Acta Neurol Scand 1978:57:350-357.
18. Elmqvist D, Lambert EH. Detailed analysis of neuromuscular transmission in a patient with myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc 1968;43:689-713.
19. Tim RW, Sanders DB. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1994;17:995-1001.
20. Oh SJ, Kim DF, Kuruoglu R, Brooks J, Claussen G. Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1996;19:903-906.
21. Mayer RF, Williams IR. Incrementing responses in myasthenia gravis. Arch Neurol 1974;31:24-26.
22. Singer P, Smith L, Wiegler DK, Festoff BW. Posttetanic potentiation in a patient with MG. Neurology 1981;31:1345-1347.
23. Oh SJ, Esmali N, Nishihira T, et al. Electrophysiological and clinical correlation in myasthenia gravis Ann Neurol 1982;12: 348-354.
24. Howard JF, Sanders DB, Massey JM. The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. Neurol Clin North Am 1994;12:305-331.
25. Özdemir C, Young RR. Electrical testing in myasthenia gravis. Ann N Y Acad Sci 1971;183:287-302.
26. Lang B, Newsom-Davis J. Immunopathology of the Lambert-Eaton myasthenic syndrome. Springer Semin Immunopathol 1995;17:3-15.
27. Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci 1987;505:472-499.
28. Oh SJ. Diverse electrophysiological spectrum of the Lambert-Baton myasthenic syndrome. Muscle Nerve 1989;12:464-469.
29. Henriksson KG, Nilson O, Rosén I, Schiller HH. Clinical, neurophysiological and morphological findings in Eaton Lambert syndrome. Acta Neurol Scand 1977;56:117-140.
30. Mcevoy KM, Windebank AJ, Daube JR, Low PA. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989;321:1567-1571.
31. Lundh H, Nilsson O, Rosen I. Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine. Neurology 1984;34:1324-1330.
32. Sano M, Lambert EH, McCormick DJ, Lennon VA. Muscle acetylcholine receptors complexed with autologous IgG reflect seropositivity but not necessarily in vivo binding. Neurology 1992;42:218-222.
33. Krolik KA, Thompson PA, Zoda TE, Mohan S, Barohn EJ, Yeh TM. Immunological factors that influence disease severity in experimental autoimmune myasthenia gravis. In: Hohfeld R, ed. Immunology of neuromuscular disease. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1994:209-234.
34. Lennon VA, Greismann GE. Evidence against acetylcholine receptor having a main immunogenic region as a target for autoantibodies in myasthenia gravis. Neurology 1989;39: 1069-1076.
35. Lennon VA. Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome. Neurology 1997;48:S23-S27.